An open randomized clinical trial in comparing two artesunate-based combination treatments on Plasmodium falciparum malaria in Nigerian children: artesunate/sulphamethoxypyrazine/pyrimethamine (fixed dose over 24 hours) versus artesunate/amodiaquine (fixed dose over 48 hours)

BACKGROUND: Several studies have demonstrated the efficacy of artemisinin-combination therapy (ACT) across malaria zones of the world. Fixed dose ACT with shorter courses and fewer tablets may be key determinants to ease of administration and compliance. METHODS: Children aged one year to 13 years p...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayede, Idowu Adejumoke, Falade, Adegoke Gbadegesin, Sowunmi, Akintunde, Jansen, Frans Herwig
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024282/
https://www.ncbi.nlm.nih.gov/pubmed/21194422
http://dx.doi.org/10.1186/1475-2875-9-378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024282/
https://www.ncbi.nlm.nih.gov/pubmed/21194422
http://dx.doi.org/10.1186/1475-2875-9-378

Ejemplares similares